David Calligaris

Citado por

	Total	Desde 2019
Citas	2671	1673
Índice h	26	20
Índice i10	32	26

380

190

285

2011201220132014201520162017201820192020202120222023202426 34 60 79 130 196 216 235 274 327 365 337 280 90

Acceso público

Ver todo

22 artículos

3 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Sandro Santagata MD PhDBWH Pathology | HMS Laboratory of Systems Pharmacology | HMS Department of SysBioDirección de correo verificada de bics.bwh.harvard.edu
De Pauw EdwinFull Professor, University of LiegeDirección de correo verificada de ulg.ac.be
Isaiah NortonBrigham and Women's Hospital, Harvard Medical SchoolDirección de correo verificada de bwh.harvard.edu
Delphine DeboisUniversity of LiègeDirección de correo verificada de ulg.ac.be
Ferenc Jolesz M.D.Harvard Medical School, Brigham and Women's HospitalDirección de correo verificada de bwh.harvard.edu
Alexandra GolbyProfessor of NeurosurgeryDirección de correo verificada de bwh.harvard.edu
Olutayo I Olubiyi, MD, MPHHarvard Medical School/Brigham and Women's HospitalDirección de correo verificada de mail.harvard.edu
Armen ChangelianDicerna PharmaceuticalsDirección de correo verificada de dicerna.com
Scott L. PomeroyBronson Crothers Professor of Neurology, Harvard Medical SchoolDirección de correo verificada de childrens.harvard.edu
Frank Fake Lu, PhDAssistant Professor of Biomedical Engineering, Binghamton University - SUNYDirección de correo verificada de binghamton.edu
Gabriel MazzucchelliUniversité de LiègeDirección de correo verificada de ulg.ac.be
Daniel A OrringerNew York UniversityDirección de correo verificada de nyulangone.org
Christopher J. ThompsonBrightSpecDirección de correo verificada de brightspec.com
Nicolas SmargiassoDirección de correo verificada de ulg.ac.be
Andrei TurtoiLab Head Tumor Microenvironment and Resistance to Treatment, IRCM Montpellier, Inserm, FranceDirección de correo verificada de inserm.fr
Robert LangerMassachusetts Institute of TechnologyDirección de correo verificada de mit.edu
james cookProfessor of Chemistry, University of Wisconsin MilwaukeeDirección de correo verificada de uwm.edu
Kashi Reddy MethukuScientist-II, Alcami CorporationDirección de correo verificada de uwm.edu
François DevredAix Marseille Univ, CNRS, UMR 7051, INP, Faculté de PharmacieDirección de correo verificada de univ-amu.fr
Rajendar K MittapalliClinical Pharmacology Lead, Pfizer Inc.Dirección de correo verificada de pfizer.com

Seguir

David Calligaris

Head of Laboratory, ImaBiotech CORP

No hay ninguna dirección de correo electrónico verificada.

Mass Spectrometry Cancer Biology Proteomics Lipidomics Drug Discovery


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery S Santagata, LS Eberlin, I Norton, D Calligaris, DR Feldman, JL Ide, X Liu, ... Proceedings of the National Academy of Sciences 111 (30), 11121-11126, 2014	290	2014
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents CF Cho, JM Wolfe, CM Fadzen, D Calligaris, K Hornburg, EA Chiocca, ... Nature communications 8 (1), 15623, 2017	255	2017
Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis D Calligaris, D Caragacianu, X Liu, I Norton, CJ Thompson, ... Proceedings of the National Academy of Sciences 111 (42), 15184-15189, 2014	253	2014
Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma CJ Braun, M Stanciu, PL Boutz, JC Patterson, D Calligaris, F Higuchi, ... Cancer cell 32 (4), 411-426. e11, 2017	200	2017
Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal NE Sounni, J Cimino, S Blacher, I Primac, A Truong, G Mazzucchelli, ... Cell metabolism 20 (2), 280-294, 2014	184	2014
Label-free neurosurgical pathology with stimulated Raman imaging FK Lu, D Calligaris, OI Olubiyi, I Norton, W Yang, S Santagata, XS Xie, ... Cancer research 76 (12), 3451-3462, 2016	147	2016
Mass spectrometry imaging as a tool for surgical decision‐making D Calligaris, I Norton, DR Feldman, JL Ide, IF Dunn, LS Eberlin, ... Journal of Mass Spectrometry 48 (11), 1178-1187, 2013	111	2013
The efficacy of the Wee1 inhibitor MK-1775 combined with temozolomide is limited by heterogeneous distribution across the blood–brain barrier in glioblastoma JL Pokorny, D Calligaris, SK Gupta, DO Iyekegbe Jr, D Mueller, ... Clinical cancer research 21 (8), 1916-1924, 2015	96	2015
Microtubule targeting agents: from biophysics to proteomics D Calligaris, P Verdier-Pinard, F Devred, C Villard, D Braguer, D Lafitte Cellular and molecular life sciences 67, 1089-1104, 2010	94	2010
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas Y Sun, JA Alberta, C Pilarz, D Calligaris, EJ Chadwick, SH Ramkissoon, ... Neuro-oncology 19 (6), 774-785, 2017	92	2017
Efficacy of PARP inhibitor rucaparib in orthotopic glioblastoma xenografts is limited by ineffective drug penetration into the central nervous system KE Parrish, L Cen, J Murray, D Calligaris, S Kizilbash, RK Mittapalli, ... Molecular cancer therapeutics 14 (12), 2735-2743, 2015	91	2015
MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation D Calligaris, DR Feldman, I Norton, O Olubiyi, AN Changelian, ... Proceedings of the National Academy of Sciences 112 (32), 9978-9983, 2015	87	2015
Advances in top-down proteomics for disease biomarker discovery D Calligaris, C Villard, D Lafitte Journal of proteomics 74 (7), 920-934, 2011	81	2011
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma EC Randall, KB Emdal, JK Laramy, M Kim, A Roos, D Calligaris, ... Nature communications 9 (1), 4904, 2018	74	2018
Rapid discrimination of pediatric brain tumors by mass spectrometry imaging AR Clark, D Calligaris, MS Regan, D Pomeranz Krummel, JN Agar, ... Journal of Neuro-oncology 140, 269-279, 2018	58	2018
Molecular typing of meningiomas by desorption electrospray ionization mass spectrometry imaging for surgical decision-making D Calligaris, DR Feldman, I Norton, PK Brastianos, IF Dunn, S Santagata, ... International journal of mass spectrometry 377, 690-698, 2015	55	2015
Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging D Calligaris, R Longuespée, D Debois, D Asakawa, A Turtoi, ... Analytical chemistry 85 (4), 2117-2126, 2013	48	2013
MALDI in-source decay of high mass protein isoforms: application to α-and β-tubulin variants D Calligaris, C Villard, L Terras, D Braguer, P Verdier-Pinard, D Lafitte Analytical chemistry 82 (14), 6176-6184, 2010	47	2010
First in vivo testing of compounds targeting group 3 medulloblastomas using an implantable microdevice as a new paradigm for drug development O Jonas, D Calligaris, KR Methuku, MM Poe, JP Francois, F Tranghese, ... Journal of biomedical nanotechnology 12 (6), 1297-1302, 2016	44	2016
Ultraviolet laser induced hydrogen transfer reaction: study of the first step of MALDI in-source decay mass spectrometry D Asakawa, D Calligaris, N Smargiasso, E De Pauw The Journal of Physical Chemistry B 117 (8), 2321-2327, 2013	43	2013

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores